Data / Form D filings / Sojournix, Inc.
Sojournix, Inc.: Form D filings
Sojournix, Inc., a pharmaceuticals company in Arlington, MA, filed 5 Form D notices with the SEC between 2016 and 2018. The latest, on November 13, 2018, reports $44 million sold of a $44 million offering to 7 investors.
Find out what Sojournix, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1167 MASSACHUSETTS AVE., Arlington, MA, 02476
- Phone
- (781) 795-4700
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1674444
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2018 | New notice | $43,999,992 | $43,999,992 | $0 | 7 | Nov 1, 2018 | sec.gov |
| Dec 21, 2017 | Amendment | $19,441,330 | $19,028,100 | $413,230 | 7 | Jul 27, 2017 | sec.gov |
| Aug 9, 2017 | New notice | $6,000,000 | $6,000,000 | $0 | 2 | Jul 27, 2017 | sec.gov |
| May 18, 2017 | Amendment | $8,363,640 | $8,363,640 | $0 | 3 | May 6, 2016 | sec.gov |
| May 17, 2016 | New notice | $7,000,000 | $2,000,000 | $5,000,000 | 2 | May 6, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Scott S. Rakestraw | Director | |
| Daniel S. Grau | Executive Officer, Director | |
| Martin S. Freed | Director | |
| Aaron S. Davis | Director | |
| Peter S. Kolchinsky | Director | |
| Peter S. Lanciano | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Nov 12, 2018 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sojournix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.